Author: ritazielinski4

Government standardises requirements of Provisional Vaccine Pass ****************************************************************      Considering that COVID-19 vaccine has been widely administered in places outside Hong Kong and the local Vaccine Pass requirements will be further strengthened (lowering the applicable age starting from September 30, and requiring all persons aged 12 or above to be vaccinated with three doses starting from the end of November), the Government announced today (September 16) revision to the Provisional Vaccine Pass applicable to all inbound travellers, requiring them to have received at least two doses starting from tomorrow (September 17).      In order to facilitate ... Read more

From optimizing particle size to choosing the right nanocarrier systems, Oligonucleotide Therapeutics and Delivery conference will address delivery to non-hepatocyte cells such as cancerous tissues and overview the most successful platforms. Download a copy of your brochure to find out who will be speaking at the upcoming conference in September www.oligonucleotide.co.uk/PRCOMpr4 Clinical Advances of RNAi Therapy Treating diseases with antibody oligonucleotide conjugates: Combining the selectivity of antibodies with the specificity of oligonucleotide drugs – Antibody oligonucleotide conjugates utilize the selectivity of antibody delivery and the specificity of oligonucleotide therapeutics to treat diseases– AOC1001 is designed to treat myotonic dystrophy type ... Read more